Spravato for Depression: What Patients With Treatment-Resistant Depression Should Know
- 4 days ago
- 5 min read
When depression does not improve after trying multiple medications, it can leave you feeling discouraged, exhausted, or unsure about what to try next. Spravato for depression offers a different treatment option for adults living with treatment-resistant depression. Unlike traditional antidepressants taken at home each day, Spravato is a prescription nasal spray administered in a certified healthcare setting under medical supervision.
For some patients, Spravato may provide relief after other treatments have not been effective. However, it is not the right choice for everyone. Understanding how it works, what treatment involves, and what questions to ask can help you have a more informed conversation with your healthcare provider.
What Is Treatment-Resistant Depression?
Treatment-resistant depression generally describes major depressive disorder that has not improved enough after a person has tried at least two antidepressant medications at adequate doses and for an appropriate amount of time.
This does not mean that your depression cannot be treated. It simply means that the approaches you have tried so far have not provided the relief you need.
Signs that depression may be treatment-resistant can include:
Symptoms that continue after trying two or more antidepressants
Only partial improvement with medication
Symptoms that return despite ongoing treatment
Medication side effects that make it difficult to continue treatment
Persistent difficulty with sleep, concentration, motivation, or daily responsibilities
Depression is complex, and there may be several reasons a treatment has not worked as expected. A healthcare provider may review your diagnosis, medication history, physical health, sleep, stress, substance use, and other factors before recommending a different approach.
What Is Spravato?
Spravato is the brand name for esketamine, a medication related to ketamine. It is administered as a nasal spray and works differently from most traditional antidepressants.
Many commonly prescribed antidepressants affect serotonin, norepinephrine, or dopamine. Esketamine primarily acts on the brain’s glutamate system, including receptors involved in communication and adaptability between brain cells. This different mechanism is one reason Spravato may be considered when standard antidepressants have not provided enough improvement.
The FDA has approved Spravato for adults with treatment-resistant depression. It may be used by itself or with an oral antidepressant. It is also approved with an oral antidepressant for depressive symptoms in adults with major depressive disorder who are experiencing acute suicidal thoughts or actions.
Spravato is not the same as at-home ketamine products or ketamine infusions. Although the medications are related, they have different formulations, approval statuses, and administration requirements.
Who May Benefit From Spravato for Depression?
Spravato may be considered for an adult who has been diagnosed with major depressive disorder and has not experienced sufficient improvement after trying at least two oral antidepressants.
A provider may also consider:
How long your depressive symptoms have continued
Which medications and therapies you have already tried
Whether previous treatments provided partial relief
How depression is affecting your work, relationships, and daily life
Your physical health and medication history
Whether you can safely attend and recover from monitored appointments
Spravato is not usually the first treatment offered for depression. Instead, it may become part of the conversation when more common treatments have not worked well enough or have caused difficult side effects.
Eligibility must be determined through a medical and psychiatric evaluation. Certain health conditions, medications, or risk factors may make Spravato inappropriate or require additional precautions.
What Happens During a Spravato Treatment Session?
Spravato cannot be picked up from a pharmacy and used at home. It must be administered at a certified treatment center participating in the required safety program.
Before treatment, the clinical team will review your health history and medications. Your blood pressure will typically be checked before you receive the medication.
During the appointment, you administer the nasal spray yourself while a healthcare professional supervises you. Afterward, you remain at the clinic for at least two hours so the care team can monitor your response. Your blood pressure and overall condition may be checked during this period.
Some people experience temporary effects such as:
Sleepiness or sedation
Dizziness
Nausea
Increased blood pressure
Changes in perception
Feeling disconnected from yourself or your surroundings
Difficulty concentrating
These effects often occur shortly after treatment and may improve during the observation period. Because Spravato can temporarily affect alertness, coordination, and judgment, patients must arrange transportation home. You should not drive or operate machinery until the following day after a restful sleep.
How Often Is Spravato Given?
Treatment typically begins with an induction phase. For treatment-resistant depression, the FDA-approved schedule generally involves two appointments per week for the first four weeks.
If the treatment is helping, appointments may become less frequent:
Twice weekly during weeks one through four
Once weekly during weeks five through eight
Once weekly or every other week beginning in week nine
The exact dose, frequency, and length of treatment depend on how well the medication is working and how you tolerate it. Your provider should regularly evaluate whether continued treatment is beneficial.
Because each appointment includes administration and monitoring time, it is important to consider transportation, work responsibilities, caregiving needs, and insurance coverage before beginning.
How Quickly Does Spravato Work?
One reason people ask about Spravato is that it may begin reducing depressive symptoms more quickly than traditional oral antidepressants for some patients. However, response times vary.
Some people notice changes relatively early in treatment. Others need several appointments before they can tell whether symptoms are improving. Some may not experience a meaningful response.
It can help to think beyond whether you suddenly “feel better.” Early improvements may be
more subtle, such as:
Getting out of bed more easily
Feeling less emotionally overwhelmed
Completing basic daily tasks
Experiencing fewer negative thoughts
Reconnecting with people or activities
Finding it easier to participate in therapy
Keeping track of these changes can help you and your provider evaluate your progress more accurately.
Does Spravato Replace Therapy or Other Depression Care?
Spravato is one potential part of a broader treatment plan. Depending on your needs, care may also include psychotherapy, medication management, sleep support, changes in daily routines, and treatment for other mental or physical health conditions.
Medication may reduce the intensity of symptoms, while therapy can help you understand patterns, process difficult experiences, strengthen coping skills, and make meaningful changes in your life. For many people, these approaches work together rather than competing with one another.
Your care plan should be personalized and adjusted as your needs change.
Questions to Ask Before Starting Treatment
If you are considering Spravato, you may want to ask your provider:
Do I meet the criteria for treatment-resistant depression?
Why are you recommending Spravato for me?
Are there medical reasons this treatment may not be safe for me?
What side effects should I expect?
How will we measure whether the treatment is working?
How often will I need to attend appointments?
Will I continue taking my current medications?
Does my insurance cover treatment?
What transportation arrangements will I need?
What happens if Spravato does not help?
A trustworthy provider should make space for these questions and explain both the possible benefits and the limitations of treatment.
Finding Support for Treatment-Resistant Depression
Trying several treatments without experiencing enough relief can be deeply frustrating. It may even lead you to believe that nothing will work. Treatment-resistant depression does not mean you are beyond help. It means your care may need to take a different direction.
For eligible adults, Spravato for depression may offer another path when traditional antidepressants have not provided sufficient relief. The decision should be made with a qualified healthcare provider who can review your treatment history, discuss possible risks, and help you understand how Spravato may fit into your larger mental health plan.
Goodwin Health Cafe provides mental health services in a welcoming, supportive environment at 5625 N. Wall St., Suite 100, Spokane, WA 99205. To learn more about available services or request an appointment, visit Goodwin Health Cafe.
Comments